Inhibiting MAPK14 showed anti-prolactinoma effect

BACKGROUND: The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38α MAPK (MAPK14), p38β (MAPK11), p38γ (MAPK12) and p38δ (MAPK13) is associated with the development and progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Qiao-yan, Zhang, Yu, Ma, Li, Chen, Yong-gang, Wu, Jin-hu, Zhang, Hong-feng, Wang, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487756/
https://www.ncbi.nlm.nih.gov/pubmed/32894113
http://dx.doi.org/10.1186/s12902-020-00619-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487756/
https://www.ncbi.nlm.nih.gov/pubmed/32894113
http://dx.doi.org/10.1186/s12902-020-00619-z

Ejemplares similares